SCHEMBL4957147

SCHEMBL4957147

CCCCc1nc2ccccc2c(=O)n1-c1ccc(N)cc1C(F)(F)F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
LMNA P02545 4/20 0.54
MAPK1 P28482 1/20 0.54
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
TSHR P16473 1/20 0.49
PDE4D Q08499 2/20 0.48
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959650 0.88 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4960674 0.84 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4959093 0.82 LMNA (0.63) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4961212 0.81 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL14115100 0.79 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4959071 0.79 ALDH1A1 (0.76) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4958923 0.79 LMNA (0.80) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4960645 0.78 LMNA (0.67) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4958449 0.77 LMNA (0.65) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4958839 0.77 ALDH1A1 (0.65) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO claimed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed